Filtros de búsqueda

Lista de obras de Alan W Partin

A Contemporary Analysis of Outcomes of Adenocarcinoma of the Prostate With Seminal Vesicle Invasion (pT3b) After Radical Prostatectomy ⬇️

artículo científico publicado el 21 de marzo de 2011

A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer

artículo científico publicado en 2011

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range ⬇️

artículo científico publicado el 17 de marzo de 2011

A New Source for Your Patient-oriented Education

artículo científico publicado en 2013

A Novel Approach for Performing Bone Marrow Aspiration at the Time of Radical Prostatectomy

artículo científico publicado en 2016

A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy

artículo científico publicado en 2016

A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy

artículo científico publicado en 2013

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

artículo científico publicado en 2014

A neurocomputational model for prostate carcinoma detection

artículo científico publicado en 2003

A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer

artículo científico publicado en 2010

A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness

artículo científico publicado en 2010

AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy

artículo científico publicado en 2011

Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program

artículo científico publicado en 2009

Activation of mammalian target of rapamycin signaling pathway markers in minute adenocarcinoma of the prostate.

artículo científico publicado en 2013

Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience ⬇️

artículo científico publicado el 4 de abril de 2011

Adenocarcinoma of the Prostate with Gleason Score 9-10 on Core Biopsy: Correlation with Findings at Radical Prostatectomy and Prognosis ⬇️

artículo científico publicado el 30 de mayo de 2013

Advances in prostate cancer treatment: highlights from the 2nd international prostate cancer congress, st. Thomas, u.s. Virgin islands, july 17-20, 2002.

artículo científico publicado en 2003

African American Men With Very Low–Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them? ⬇️

artículo científico publicado el 17 de junio de 2013

Allogeneic versus autologous blood transfusion and survival after radical prostatectomy

artículo científico publicado en 2014

An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care

artículo científico publicado en 2016

An experimental strategy for quantitative analysis of the humoral immune response to prostate cancer antigens using natural protein microarrays

artículo científico publicado en 2007

An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011.

artículo científico publicado en 2012

Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2.

artículo científico publicado en 2009

Analytical Validation of Androgen Receptor Splice Variant 7 Detection in a Clinical Laboratory Improvement Amendments (CLIA) Laboratory Setting

artículo científico publicado en 2016

Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias

artículo científico publicado en 2007

Applying complexed prostate-specific antigen to clinical practice

artículo científico publicado en 2004

Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.

artículo científico publicado en 2017

Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans

artículo científico publicado en 2008

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans

artículo científico publicado en 2007

Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer

artículo científico publicado en 2012

Association of prostate cancer risk variants with clinicopathologic characteristics of the disease

artículo científico publicado en 2008

Best of the 2007 AUA Annual Meeting: Highlights from the 2007 Annual Meeting of the American Urological Association, May 19-24, 2007, Anaheim, CA.

artículo científico publicado en 2007

Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL.

artículo científico publicado en 2009

Best of the 2014 AUA Annual Meeting: Highlights From the 2014 American Urological Association Annual Meeting, May 16-21, 2014, Orlando, FL.

artículo científico publicado en 2014

Best of the 2015 AUA Annual Meeting: Highlights From the 2015 American Urological Association Annual Meeting, May 15-19, 2015, New Orleans, LA

artículo científico publicado en 2015

Best of the 2017 AUA Annual Meeting: Highlights From the 2017 American Urological Association Annual Meeting, May 12-16, 2017, Boston, MA.

artículo científico publicado en 2017

Best of the 2018 AUA Annual Meeting

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer

artículo científico publicado en 2003

Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b

artículo científico publicado en 2004

Biochemical relapse after primary treatment for prostate cancer: studies on natural history and therapeutic considerations

artículo científico publicado en 2004

Biomarkers for prostate cancer

artículo científico publicado en 2009

Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease

artículo científico publicado en 2004

Bisphosphonates in metastatic prostate cancer.

artículo científico publicado en 2003

Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center

artículo científico publicado en 2006

Body Mass Index and Prostate Specific Antigen as Predictors of Adverse Pathology and Biochemical Recurrence After Prostatectomy

article

CLINICAL EVALUATION OF AN EPIGENETIC ASSAY TO PREDICT MISSED CANCER IN PROSTATE BIOPSY SPECIMENS.

artículo científico publicado en 2016

Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?

artículo científico publicado en 2003

Can urinary PCA3 supplement PSA in the early detection of prostate cancer?

artículo científico publicado en 2014

Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?

artículo científico publicado en 2002

Causes of Death After Radical Prostatectomy at a Large Tertiary Center ⬇️

artículo científico publicado el 20 de julio de 2012

Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy

artículo científico publicado en 2016

Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.

artículo científico publicado en 2006

Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study

artículo científico publicado en 2011

Clinical interpretation of prostate biopsy reports

artículo científico publicado en 2006

Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%.

artículo científico

Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies

artículo científico

Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer

artículo científico publicado en 2017

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

scientific journal article

Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer

artículo científico publicado en 2002

Comparison of Biochemical Recurrence–Free Survival Between Periprostatic and Pelvic Lymph Node Metastases of Prostate Cancer ⬇️

artículo científico publicado el 5 de abril de 2013

Comparison of logistic regression and neural net modeling for prediction of prostate cancer pathologic stage.

artículo científico publicado en 2002

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade

artículo científico publicado en 2005

Comparison of total prostate-specific antigen and derivative levels in a screening population of black, white, and Korean-American men.

artículo científico publicado en 2003

Complexed Prostate Specific Antigen Improves Specificity for Prostate Cancer Detection: Results of a Prospective Multicenter Clinical Trial ⬇️

artículo científico publicado el 1 de noviembre de 2003

Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA.

artículo científico publicado en 2004

Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men.

artículo científico publicado en 2002

Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter

artículo científico publicado en 2002

Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins

artículo científico publicado en 2006

Contemporaneous comparison of open vs minimally‐invasive radical prostatectomy for high‐risk prostate cancer ⬇️

artículo científico publicado el 28 de enero de 2013

Correlation of postoperative pain to quality of recovery in the immediate postoperative period

artículo científico publicado en 2005

Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screening

artículo científico publicado en 2002

CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer

artículo científico publicado en 2008

Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations

artículo científico publicado en 2008

Cyr61 is regulated by cAMP‐dependent protein kinase with serum levels correlating with prostate cancer aggressiveness ⬇️

artículo científico publicado el 24 de octubre de 2011

DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer prediction

artículo científico publicado en 2009

DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme

artículo científico publicado en 2009

Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population

artículo científico publicado en 2004

Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation.

artículo científico publicado en 2017

Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?

artículo científico publicado en 2007

Docetaxel in androgen-independent prostate cancer: an update

artículo científico publicado en 2004

Does laterality of positive needle biopsy in clinical T2a patients with prostate cancer affect biochemical recurrence-free survival?

artículo científico publicado en 2008

EPCA-2: a highly specific serum marker for prostate cancer

artículo científico publicado en 2007

Early Detection of Prostate Cancer Continues to Support Rational, Limited Screening ⬇️

artículo científico publicado el 18 de mayo de 2013

Effect of DNA methylation on identification of aggressive prostate cancer

artículo científico publicado en 2008

Effect of intra-observer variation in prostate volume measurement on prostate-specific antigen density calculations among prostate cancer active surveillance participants

artículo científico publicado en 2011

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

artículo científico publicado en 2006

Efficacy of continuous local anesthetic infusion for postoperative pain after radical retropubic prostatectomy

artículo científico publicado en 2005

Endoglin (CD105) as a urinary and serum marker of prostate cancer

artículo científico publicado en 2009

Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies

artículo científico publicado en 2011

Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml

artículo científico

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility

artículo científico publicado en 2005

Evaluation of two mitochondrial DNA biomarkers for prostate cancer detection

artículo científico publicado en 2015

Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12

artículo científico publicado en 2008

Evolution of the clinical presentation of men undergoing radical prostatectomy for high‐risk prostate cancer ⬇️

artículo científico publicado el 22 de agosto de 2011

Expectant management of localized prostate cancer

artículo científico publicado en 2003

External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score

artículo científico publicado en 2008

Fifth-Generation Digital Immunoassay for Prostate-Specific Antigen by Single Molecule Array Technology ⬇️

artículo científico publicado el 13 de octubre de 2011

Free prostate-specific antigen in serum is becoming more complex

artículo científico publicado en 2002

Genetic tests for prostate cancer.

artículo científico publicado en 2013

Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

artículo científico publicado en 2007

Geometric Evaluation of Systematic Transrectal Ultrasound Guided Prostate Biopsy ⬇️

artículo científico publicado el 22 de octubre de 2012

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

artículo científico publicado en 2016

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

artículo científico publicado en 2002

Germline mutations in HOXB13 and prostate-cancer risk

artículo científico publicado en 2012

Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer? ⬇️

artículo científico publicado el 10 de diciembre de 2012

Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?

artículo científico publicado en 2002

High Prevalence of screen-detected prostate cancer in West Africa: Implications for racial disparity of prostate cancer

artículo científico publicado en 2014

High-grade prostatic adenocarcinoma present in a single biopsy core is associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy

artículo científico publicado en 2011

Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer

artículo científico publicado en 2003

Identification of men with the highest risk of early disease recurrence after radical prostatectomy

artículo científico publicado en 2014

Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen

artículo científico publicado en 2003

Impact of Robotic Technique and Surgical Volume on the Cost of Radical Prostatectomy ⬇️

artículo científico publicado el 7 de diciembre de 2012

Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching

artículo científico publicado en 2008

Impact of surgical margin status on prostate‐cancer‐specific mortality ⬇️

artículo científico publicado el 12 de julio de 2012

Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching ⬇️

artículo científico publicado el 2 de noviembre de 2010

Implementation of a Surgeon-Level Comparative Quality Performance Review to Improve Positive Surgical Margin Rates during Radical Prostatectomy

artículo científico publicado en 2016

Importance of Reporting the Gleason Score at the Positive Surgical Margin Site: Analysis of 4,082 Consecutive Radical Prostatectomy Cases

artículo científico publicado en 2015

Increased Incidence of Pathologically Nonorgan Confined Prostate Cancer in African-American Men Eligible for Active Surveillance ⬇️

artículo científico publicado el 7 de marzo de 2013

Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas

artículo científico publicado en 2011

Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols

artículo científico publicado en 2014

Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients

artículo científico publicado en 2009

Initial Experience Performing in-Office Ultrasound-Guided Transperineal Prostate Biopsy Under Local Anesthesia Using the PrecisionPoint Transperineal Access System

artículo científico publicado en 2018

Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay

artículo científico publicado en 2012

Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?

artículo científico publicado en 2014

Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?

artículo científico publicado en 2008

Is prostate-specific antigen surveillance necessary in men with benign prostate pathology following radical cystoprostatectomy for bladder cancer?

artículo científico publicado en 2010

Kinetics of tumor growth of prostate carcinoma estimated using prostate-specific antigen

artículo científico publicado en 2005

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

artículo científico publicado en 2009

Long Term-Survival after Radical Prostatectomy for men with High Gleason Sum.

artículo científico publicado en 2010

Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis

artículo científico publicado en 2008

Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.

artículo científico publicado en 2003

Long-term pooled analysis of multicenter studies of cooled thermotherapy for benign prostatic hyperplasia results at three months through four years

artículo científico publicado en 2004

Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen

artículo científico publicado en 2010

Management of high-risk populations with locally advanced prostate cancer

artículo científico publicado en 2003

Management of patients with an increasing prostate-specific antigen after radical prostatectomy

artículo científico publicado en 2004

Metabolic factors associated with benign prostatic hyperplasia

artículo científico publicado en 2006

Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity

artículo científico publicado en 2003

Modeling grade progression in an active surveillance study

artículo científico publicado en 2013

Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI).

artículo científico publicado en 2003

Multiparametric magnetic resonance imaging findings in men with low‐risk prostate cancer followed using active surveillance ⬇️

artículo científico publicado el 6 de marzo de 2013

Multiple cores of Gleason score 6 correlate with favourable findings at radical prostatectomy ⬇️

artículo científico publicado el 25 de enero de 2013

Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy

artículo científico publicado en 2008

New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer

artículo científico publicado en 2016

New serum tests for the diagnosis of prostate cancer

artículo científico publicado el 1 de septiembre de 2001

Nomograms for clinically localized prostate cancer. Part I: radical prostatectomy.

artículo científico publicado en 2002

Obesity and capsular incision at the time of open retropubic radical prostatectomy

artículo científico publicado en 2005

Obesity and long-term survival after radical prostatectomy

artículo científico publicado en 2014

Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer

artículo científico publicado en 2007

Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature

artículo científico publicado en 2014

PCA3: a molecular urine assay for predicting prostate biopsy outcome

artículo científico publicado en 2008

PROSTATE BIOPSY OUTCOME PREDICTION – COMPARISON OF A NOVEL LOGISTIC REGRESSION-BASED MODEL, THE PROSTATE CANCER RISK CALCULATOR AND PSA ALONE

PSA markers in prostate cancer detection

artículo científico publicado en 2003

PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients

artículo científico publicado en 2011

Pathological Outcomes in Men with Low Risk and Very Low Risk Prostate Cancer: Implications on the Practice of Active Surveillance ⬇️

artículo científico publicado el 30 de abril de 2013

Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series

artículo científico publicado en 2016

Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience

artículo científico publicado en 2013

Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml

artículo científico publicado en 2006

Patterns of Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy for Low-risk Men.

artículo científico publicado en 2017

Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range

artículo científico publicado en 2002

Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy

artículo científico publicado en 2017

Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers

artículo científico publicado en 2009

Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpoint

artículo científico publicado en 2007

Predicting 15-year prostate cancer specific mortality after radical prostatectomy

artículo científico publicado en 2011

Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers

artículo científico publicado en 2009

Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone

artículo científico publicado en 2008

Predicting the risk of non-organ-confined prostate cancer when perineural invasion is found on biopsy

artículo científico publicado en 2014

Prediction of mortality after radical prostatectomy by Charlson comorbidity index

artículo científico publicado en 2010

Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.

artículo científico publicado en 2016

Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge

artículo científico publicado en 2002

Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy

artículo científico publicado en 2012

Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy

artículo científico publicado en 2005

Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancer

artículo científico publicado en 2009

ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program ⬇️

artículo científico publicado el 8 de enero de 2011

Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer

artículo científico publicado en 2003

Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysis

artículo científico

Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer

artículo científico publicado en 2017

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system

artículo científico publicado en 2013

Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomy

artículo científico publicado en 2008

Progress toward identifying aggressive prostate cancer

artículo científico publicado en 2004

Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy

artículo científico publicado en 2005

Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration

artículo científico publicado en 2012

Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men.

artículo científico publicado en 2015

Prostate Health Index density improves detection of clinically significant prostate cancer

artículo científico publicado en 2017

Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer

artículo científico publicado en 2016

Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study

artículo científico publicado en 2017

Prostate cancer early detection clinical practice guidelines in oncology

artículo científico publicado en 2003

Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram.

artículo científico publicado en 2009

Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissue

artículo científico publicado en 2004

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy

artículo científico publicado en 2008

Prostate specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore Longitudinal Study of Aging

artículo científico publicado en 2002

Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy

artículo científico publicado en 2008

Prostate-specific antigen as a marker of disease activity in prostate cancer.

artículo científico publicado en 2002

Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancer

artículo científico publicado en 2003

Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program

artículo científico publicado en 2010

Prostate-specific antigen: update 2006.

artículo científico publicado en 2006

Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study

artículo científico publicado en 2003

Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up

artículo científico publicado en 2014

Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenarians

artículo científico publicado en 2010

Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma

artículo científico publicado en 2008

Risk Factors for Intraprostatic Incision into Malignant Glands at Radical Prostatectomy

artículo científico publicado en 2014

Risk factors for metastatic prostate cancer: A sentinel event case series.

artículo científico publicado en 2017

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

artículo científico publicado en 2005

Robotic prostatectomy diffusion safety concerns: reality or just illusion?

artículo científico publicado en 2014

Role of biobanking in urology: a review

artículo científico publicado en 2016

SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression

artículo científico publicado en 2007

SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer

artículo científico publicado en 2007

SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort.

artículo científico publicado en 2016

Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism

artículo científico publicado en 2002

Serum prostate‐specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density ⬇️

artículo científico publicado el 7 de junio de 2013

Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis

artículo científico publicado en 2007

Small integrin-binding proteins as serum markers for prostate cancer detection

artículo científico publicado en 2009

Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational study

artículo científico publicado en 2014

Standardization of two immunoassays for human glandular kallikrein 2.

artículo científico publicado en 2003

Surgical margin status after radical retropubic prostatectomy

artículo científico publicado en 2005

Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk

artículo científico publicado en 2015

The Evolving Role of Docetaxel in the Management of Androgen Independent Prostate Cancer ⬇️

artículo científico publicado el 1 de noviembre de 2003

The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate

artículo científico publicado en 2002

The impact of preoperative erectile dysfunction on survival after radical prostatectomy

artículo científico publicado en 2010

The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator

artículo científico publicado en 2013

The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy

artículo científico publicado en 2007

The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up

artículo científico publicado en 2011

The prostate health index selectively identifies clinically significant prostate cancer

artículo científico publicado en 2014

Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.

artículo científico publicado en 2015

Treatment decision‐making for localized prostate cancer: What younger men choose and why ⬇️

artículo científico publicado el 25 de abril de 2011

Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays

artículo científico publicado en 2004

Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experience

artículo científico publicado en 2013

Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005

artículo científico publicado en 2007

Updating risk prediction tools: a case study in prostate cancer

artículo científico publicado en 2011

Urinary Biomarkers for Prostate Cancer

artículo científico publicado en 2016

Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent

artículo científico publicado en 2008

Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men.

artículo científico publicado en 2015

Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma

artículo científico publicado en 2002

Validation of the partin nomogram for prostate cancer in a national sample

artículo científico publicado en 2010

Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence

artículo científico publicado en 2012

[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study

scientific article published on 11 June 2008

p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape

artículo científico publicado en 2008

¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda